• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SLC29A3 Blocking Peptide

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS153993

MBS153993 is a blocking peptide targeting SLC29A3. Also known as SLC29A3 Peptide. More details

$210 / 0.05 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SLC29A3, Blocking Peptide
Full Product Name
SLC29A3 Peptide
Product Gene Name
Product Synonym Names
Solute carrier family 29 member 3; Equilibrative nucleoside transporter 3; ENT3; HCLAP; HJCD; PHID; solute carrier family 29 (equilibrative nucleoside transporter), member 3
Form/Format
Liquid
Concentration
200 ug/mL (lot specific)
Preparation and Storage
Store SLC29A3 peptide at -20 degree C, stable for one year.
Antibody/Peptide Pairs
SLC29A3 peptide (MBS153993) is used for blocking the activity of SLC29A3 antibody (MBS153540)
Molecular Weight
35,502 Da
OMIM
phenotype 612373
Species
Human
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location
19 amino acid peptide near the amino terminus of human SLC29A3.
Applications Tested/Suitable for SLC29A3 blocking peptide
Blocking (BL)
Application Notes for SLC29A3 blocking peptide
SLC29A3 peptide is used for blocking the activity of SLC29A3 antibody.

Other Notes

Small volumes of SLC29A3 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for SLC29A3. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
equilibrative nucleoside transporter 3 isoform a
NCBI Official Synonym Full Names
solute carrier family 29 (equilibrative nucleoside transporter), member 3
NCBI Official Symbol
SLC29A3
NCBI Official Synonym Symbols
ENT3; HJCD; PHID; HCLAP
UniProt Protein Name
Equilibrative nucleoside transporter 3
UniProt Synonym Protein Names
Solute carrier family 29 member 3
UniProt Gene Name
SLC29A3
UniProt Synonym Gene Names
ENT3; hENT3
UniProt Entry Name
S29A3_HUMAN
NCBI Protein Information
equilibrative nucleoside transporter 3; solute carrier family 29 (nucleoside transporters), member 3

NCBI Summary for SLC29A3

This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]
Show more

UniProt Comments for SLC29A3

SLC29A3: Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). Mediates transport of adenine, adenosine and uridine, as well as several nucleoside analog drugs, such as anticancer and antiviral agents, including cladribine, cordycepin, tubercidin and AZT. Does not transport hypoxanthine. Defects in SLC29A3 are the cause of histiocytosis- lymphadenopathy plus syndrome (HLAS). A syndrome characterized by the combination of features from 2 or more of four histiocytic disorders, originally thought to be distinct: Faisalabad histiocytosis (FHC), sinus histiocytosis with massive lymphadenopathy (SHML), H syndrome, and pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (PHID). FHC features include joint deformities, sensorineural hearing loss, and subsequent development of generalized lymphadenopathy and swellings in the eyelids that contain histiocytes. SHML causes lymph node enlargement in children frequently accompanied by fever, leukocytosis, elevated erythrocyte sedimentation rate, and polyclonal hypergammaglobulinemia. H syndrome is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism; hearing loss is found in about half of patients. PHID is characterized by predominantly antibody-negative insulin-dependent diabetes mellitus associated with pigmented hypertrichosis and variable occurrence of other features of H syndrome. Belongs to the SLC29A/ENT transporter (TC 2.A.57) family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Transporter, SLC family; Membrane protein, integral; Membrane protein, multi-pass; Transporter

Chromosomal Location of Human Ortholog: 10q22.1

Cellular Component: late endosome membrane; lysosomal membrane; integral to membrane

Molecular Function: nucleoside transmembrane transporter activity

Biological Process: transmembrane transport

Disease: Histiocytosis-lymphadenopathy Plus Syndrome
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000